Gammaked (immune globulin injection (human) 10% caprylate/chromatography purified])
/ Kedrion
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
September 29, 2020
Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID)
(clinicaltrials.gov)
- P3; N=47; Active, not recruiting; Sponsor: Kedrion S.p.A.; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Immunology • Primary Immunodeficiency • HP
May 23, 2019
Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID)
(clinicaltrials.gov)
- P3; N=50; Recruiting; Sponsor: Kedrion S.p.A.
New P3 trial
1 to 2
Of
2
Go to page
1